HomeNewscoronavirusCovid-19 Pandemic | Double mutant, 'variants of concern' in 18 Indian states: Health Ministry

Covid-19 Pandemic | Double mutant, 'variants of concern' in 18 Indian states: Health Ministry

Despite the detection of mutated variants, the Indian health ministry has refrained from linking the recent surge in infections to the evolved virus strains.

March 24, 2021 / 16:18 IST
Story continues below Advertisement
India has witnessed a resurgence in COVID-19 infections since mid-February (File image)
India has witnessed a resurgence in COVID-19 infections since mid-February (File image)

The Union health ministry on March 24 flagged the presence of a 'double mutant variant' and a number of 'variants of concern (VOCs)' in 18 Indian states. The mutated strains of COVID-19 have been identified amid a recent surge in infections across the nation.

The government, however, said the mutated variants "have not been detected in numbers sufficient to either establish or direct relationship or explain the rapid increase in cases in some states".

Story continues below Advertisement

Genomic sequencing and epidemiological studies are continuing to further analyse the situation, the government said.

In other parts of the world which witnessed a second wave of the pandemic, the evolved strain of coronavirus was attributed as the primary reason for the resurgence of health crisis.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show